Non Small Cell Lung Cancer Keytruda Drug

Keytruda is a prescription medicine used to treat a kind of lung cancer called non small cell lung cancer nsclc.

Non small cell lung cancer keytruda drug.

Non small cell lung cancer is cancer of the lung which is not small cell carcinoma. The following information is not intended to endorse any particular medication. While these reviews might be helpful they are not a substitute for the expertise knowledge and judgement of healthcare practitioners. Drugs used to treat non small cell lung cancer the following list of medications are in some way related to or used in the treatment of this condition.

Merck co s keytruda may be the star in non small cell lung cancer but a combo of it and chemo just failed to significantly outdo chemo alone at prolonging patients lives in small cell. User reviews for keytruda to treat non small cell lung cancer. While these reviews might be helpful they are not a substitute for the expertise knowledge and judgement of healthcare practitioners. As a first treatment keytruda chemotherapy has been proven to help patients live longer compared to chemotherapy alone a clinical trial compared patients with advanced nonsquamous non small cell lung cancer who received keytruda in combination with chemotherapy with those who received chemotherapy alone.

User reviews for keytruda to treat non small cell lung cancer page 2 the following information is not intended to endorse any particular medication. On june 17 2019 the food and drug administration granted accelerated approval to pembrolizumab keytruda merck for patients with metastatic small cell lung cancer sclc with disease. Keytruda may be used with the chemotherapy medicines pemetrexed and a platinum as your first treatment when your lung cancer has spread advanced nsclc and is a type called nonsquamous and your tumor does not have an abnormal egfr or alk gene.